• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    2/10/22 8:27:52 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email
    SC 13G/A 1 tv01423-mettlertoledointerna.htm SCHEDULE 13G/A mettlertoledointernationalinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 9)*

    Name of issuer:  Mettler-Toledo International Inc.

    Title of Class of Securities:  Common Stock

    CUSIP Number:  592688105

    Date of Event Which Requires Filing of this Statement: December 31, 2021

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  592688105

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    39,216

    7.  SOLE DISPOSITIVE POWER

    2,420,759

    8.  SHARED DISPOSITIVE POWER

    95,519

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    2,516,278

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    10.95%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Mettler-Toledo International Inc.

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    1900 Polaris Parkway
    Columbus, OH 43240

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    592688105

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 9, 2022

    By /s/ Christine M. Buchanan
    Name: Christine M. Buchanan
    Title:  Principal

    Get the next $MTD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    6/24/2025$1325.00Overweight
    Barclays
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    More analyst ratings

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pablo Perversi to Join METTLER TOLEDO Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division for Barry Callebaut from 2017 to 2022. Before that, he held various roles of increasing responsibility at Unilever from 1993 to 2017, his last position there being Vice President of Foods Europe. Roland Diggelmann, Chair of the Board, stated, "Pablo is a very accomplished

    8/4/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Reports Second Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced second quarter results for 2025. Provided below are the highlights: Reported sales increased 4% compared with the prior year. In local currency, sales increased 2% compared with the prior year. Net earnings per diluted share as reported (EPS) were $9.76, compared with $10.37 in the prior-year period. Adjusted EPS was $10.09, an increase of 5% over the prior-year amount of $9.65. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Second Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We are pleased with our second qu

    7/31/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. to Host Second Quarter 2025 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its second quarter 2025 financial results after the market close on Thursday, July 31, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and o

    7/8/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Head of Process Analytics Keller Gerry exercised 165 shares at a strike of $720.81 and sold $215,926 worth of shares (165 units at $1,308.64) (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    8/18/25 10:43:24 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Salice Thomas P exercised 1,062 shares at a strike of $312.36 and sold $1,381,560 worth of shares (1,062 units at $1,300.90) (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    8/15/25 10:16:47 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Financial Officer Vadala Shawn exercised 300 shares at a strike of $397.95 and sold $376,227 worth of shares (300 units at $1,254.09) (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    8/12/25 11:41:40 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    SEC Filings

    View All

    Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    8/4/25 4:37:43 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Mettler-Toledo International Inc.

    10-Q - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    8/1/25 2:52:04 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    7/31/25 5:53:10 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    11/15/23 9:00:20 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Mettler-Toledo with a new price target

    Barclays initiated coverage of Mettler-Toledo with a rating of Overweight and set a new price target of $1,325.00

    6/24/25 8:08:56 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo upgraded by UBS with a new price target

    UBS upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,350.00

    5/20/25 8:01:57 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo upgraded by Jefferies with a new price target

    Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

    5/5/25 8:42:51 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Financials

    Live finance-specific insights

    View All

    Mettler-Toledo International Inc. Reports Second Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced second quarter results for 2025. Provided below are the highlights: Reported sales increased 4% compared with the prior year. In local currency, sales increased 2% compared with the prior year. Net earnings per diluted share as reported (EPS) were $9.76, compared with $10.37 in the prior-year period. Adjusted EPS was $10.09, an increase of 5% over the prior-year amount of $9.65. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Second Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We are pleased with our second qu

    7/31/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. to Host Second Quarter 2025 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its second quarter 2025 financial results after the market close on Thursday, July 31, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and o

    7/8/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Reports First Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

    5/1/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    View All

    Pablo Perversi to Join METTLER TOLEDO Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division for Barry Callebaut from 2017 to 2022. Before that, he held various roles of increasing responsibility at Unilever from 1993 to 2017, his last position there being Vice President of Foods Europe. Roland Diggelmann, Chair of the Board, stated, "Pablo is a very accomplished

    8/4/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Announces Change to Board of Directors

    Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

    11/23/22 8:00:00 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/13/24 5:09:38 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/23 1:38:29 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/22 5:03:51 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials